Biofrontera Inc. (BFRI)
Data as of , from SEC Form 4 filings.
See up to 3 months of BFRI. The 7-day demo opens the 1M and 3M ranges and puts BFRI on your watchlist.
Start 7-day demoLatest BFRI insider trades
About Biofrontera Inc. (BFRI)
Biofrontera Inc. is an SEC registrant, filing under CIK 0001858685, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. It filed a registration statement with the SEC on 5 December 2025 and has not yet priced an offering.
BFRI Form 4 activity by transaction type, last 90 days
No Form 4 activity for BFRI in the last 90 days.
BFRI insider transactions (Form 4)
3217 Form 4 filings on record, the earliest from Jul 22, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Hermann Luebbert - Officer | Option exercise | Common Stock | 62,500 | - footnote F1 | - | |
| Hermann Luebbert - Officer | Option exercise | Restricted Stock Units | 62,500 | $0.00 | - | |
| ||||||
| Eugene Frederick Leffler - Officer | Option exercise | Common Stock | 31,250 | - footnote F1 | - | |
| Eugene Frederick Leffler - Officer | Option exercise | Restricted Stock Units | 31,250 | $0.00 | - | |
| ||||||
| Kevin Daniel Weber - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Hermann Luebbert - Officer | Option exercise | Restricted Stock Units | 137,500 | $0.00 | - | |
| Hermann Luebbert - Officer | Option exercise | Common Stock | 137,500 | - footnote F1 | - | |
| Hermann Luebbert - Officer | Grant or award | Restricted Stock Units | 125,000 | $0.00 | - | |
| Hermann Luebbert - Officer | Grant or award | Employee stock option (right to buy) | 125,000 | $0.00 | - | |
| ||||||
| Eugene Frederick Leffler - Officer | Grant or award | Restricted Stock Units | 62,500 | $0.00 | - | |
| Eugene Frederick Leffler - Officer | Grant or award | Employee stock option (right to buy) | 62,500 | $0.00 | - | |
| Eugene Frederick Leffler - Officer | Option exercise | Restricted Stock Units | 87,500 | $0.00 | - | |
| Eugene Frederick Leffler - Officer | Option exercise | Common Stock | 87,500 | - footnote F1 | - | |
| ||||||
| Heikki Lanckriet - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Beth J. Hoffman - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| George Patrick Jones - Officer | Grant or award | Restricted Stock Units | 50,000 | $0.00 | - | |
| George Patrick Jones - Officer | Grant or award | Employee stock option (right to buy) | 50,000 | $0.00 | - | |
| John J. Borer III - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Hermann Luebbert - Officer | Option exercise | Common Stock | 137,500 | - | - | |
| Hermann Luebbert - Officer | Grant or award | Restricted Stock Units | 125,000 | $0.00 | - | |
| Hermann Luebbert - Officer | Grant or award | Employee stock option (right to buy) | 125,000 | $0.00 | - | |
| Hermann Luebbert - Officer | Option exercise | Restricted Stock Units | 137,500 | $0.00 | - | |
| Eugene Frederick Leffler - Officer | Option exercise | Common Stock | 87,500 | - | - | |
| Eugene Frederick Leffler - Officer | Grant or award | Restricted Stock Units | 62,500 | $0.00 | - | |
| Eugene Frederick Leffler - Officer | Grant or award | Employee stock option (right to buy) | 62,500 | $0.00 | - | |
| Eugene Frederick Leffler - Officer | Option exercise | Restricted Stock Units | 87,500 | $0.00 | - | |
| Biofrontera AG - Director | Open-market purchase | Series D Convertible Preferred Stock | 3,019 | - | - | |
| George Patrick Jones - Officer | Grant or award | Employee stock option (right to buy) | 100,000 | $0.00 | - | |
| Kevin Daniel Weber - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Heikki Lanckriet - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Beth J. Hoffman - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| John J. Borer III - Director | Grant or award | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
BFRI insider trading FAQ
What is the latest insider trade for BFRI?
Biofrontera Inc. (BFRI) has filed no insider reports in the last 90 days. The most recent on record is dated 29 July 2026. The full record for BFRI runs to 17 Form 4 filings, the earliest from 22 July 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BFRI stock?
No insider purchases of BFRI were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling BFRI stock?
No insider sales of BFRI were filed in the last 90 days.
Where can I see BFRI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BFRI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Hermann Luebbert view on EDGAR
- - Eugene Frederick Leffler view on EDGAR
- - Kevin Daniel Weber view on EDGAR
- - Hermann Luebbert view on EDGAR
- - Eugene Frederick Leffler view on EDGAR
- - Heikki Lanckriet view on EDGAR
- - Beth J. Hoffman view on EDGAR
- - George Patrick Jones view on EDGAR
- - John J. Borer III view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BFRI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BFRI with a 7-day demo
- BFRI on your watchlist
- Every BFRI Form 4 filing on record
- Up to 3 months of BFRI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
